The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.

The New York Times reports that a new poll finds trust in science and scientists has increased with the COVID-19 pandemic.

Some grant applications denied funding due to an Australian Research Council rule change have now been funded following an appeal, the Guardian reports.

Vox writes that the detection of the Omicron SARS-CoV-2 variant highlights the need for improved viral genomic surveillance.

In Nature this week: plant genome sequencing dominated by affluent countries, and more.

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.